Latest news for Biosyent (OTC:BIOYF) Stock

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ACSAY

AMSC

APRN

APTS

ARCH

AVGR

AVMR

BIOYF

BKKLY

BLAGF

BNFT

BSAC

BTUMF

CALM

CEIX

CHRW

CMPNF

CPIHF

CULP

EGLE

ELGX

EVTI

FLWPF

GBLTF

GGBXF

GLBS

HAFC

HMNY

HNRG

HRTG

IDYLF

IMAX

IMXI

IOUFF

JROOF

KOIOS BEVERAGE CORP by Koios Beverage Corp.

KBEVF

KELYA

KPIFF

KRKR

LFUGF

LIFZF

LKCO

LINK RESERVATIONS INC by Link Reservations Inc.

LRSV

MGPI

MGYOY

MMJJF

MMLP

MRIB

MSPC

NAKD

NORZF

NPSGF

ORAN

OWPC

PALAF

RDWD

RAVENQUEST BIOMED INC by Ravenquest Biomed Inc.

RVVQF

SBOW

SCOO

Sinopec Shangai Petrochemical Company Ltd

SIEB

SYZLF

TBAKF

TESS

TISI

TMMFF

TSRYF

TSRYY

UNIR

WDRP

WISA

WSBC

XCPT

YGYI

UUUU

VRSRF

Stocks That Hit 52-Week Lows On Wednesday

AHPI

AKMNF

APCOF

ASDN

AXAS

BIEI

BSQR

BTLLF

CBLI

CRWD

CURN

CWEGF

CYIG

DFFN

DOYU

EBRGF

ECDP

ENLC

EPEGQ

ESTR

FIXX

FRHLF

FTSI

FTXP

GAXY

GLAC

GLDFF

GNLN

GNPX

GTLS

GTY Technology Holdings, Inc. - Class A Ordinary Shares

GTYH

HITIF

IDFB

INND

INPX

IONKF

IPCIF

ISWH

ITKG

KERN

KLDO

KENADYR MINING HLD CP ORD by Kenadyr Mining Holdings Corp

KNDYF

KNSA

LAIX

LDSR

LEMIF

LFCOF

LGF-A

LGF-B

LVRLF

MAYS

MINE

MOTS

MRMD

MTDR

MYMMF

NSTM

OPMZ

PGHEF

PPSI

PVBC

PWVI

RLLVF

RMNI

RIGHT ON BRANDS INC by Right On Brands, Inc.

RTON

RVSDF

SBPH

SCPL

SFIV

SHLO

SLCA

SMTTF

SOLCF

SVIN

TCHC

TEUM

TMDI

TRXXF

TTNP

VIAB

VTLR

WTRH

SMTS

BFARF

LLEX

SCYYF

AXXDF

SWYDF

ENSV

Stocks That Hit 52-Week Lows On Thursday

Biosyent Inc

BioSyent  declares CAD 0.04 dividend

BioSyent Inc. 2023 Q2 - Results - Earnings Call Presentation

BioSyent GAAP EPS of C$0.20, revenue of C$8.87M

BioSyent announces renewal of normal course issuer bid

BioSyent  raises quarterly dividend by 12.5% to   CAD 0.045/sahre

BioSyent GAAP EPS of C$0.12, revenue of C$7.98M

BioSyent Inc. (BIOYF) Q4 2023 Earnings Call Transcript

BioSyent declares CAD 0.045 dividend

BioSyent GAAP EPS of C$0.15, revenue of C$7.73M

Biosyent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Biosyent

News

Latest news for Biosyent (OTC:BIOYF) Stock

Wednesday, January 29, 2020

Thursday, October 17, 2019